Doximity insider files Form 144 to sell $600k in shares

Rhea-AI Filing Summary

The Form 144 filing submitted on behalf of Doximity, Inc. (DOCS) discloses a proposed sale of 10,000 common shares through broker Morgan Stanley Smith Barney LLC. The shares—acquired via a stock-option exercise on 06/25/2025—carry an aggregate market value of $600,000. With 187,826,153 shares outstanding, the transaction represents roughly 0.005 % of total shares, indicating an immaterial dilution impact. The seller reported no prior sales in the last three months and affirmed awareness of no undisclosed adverse information. The planned sale is scheduled for on or after 06/25/2025 on the NYSE under Rule 144, reflecting routine insider liquidity while complying with SEC disclosure requirements.

Positive

• Transparent disclosure under Rule 144 signals adherence to compliance standards.

Negative

• Insider share sale, albeit small, can be perceived as reduced insider confidence.

Insights

Securities Analyst

TL;DR: Minor Rule 144 sale (10k shares, $600k) — negligible dilution; signals routine insider liquidity, neutral impact.

The filing details a single insider’s intent to sell 10,000 DOCS shares, worth about $600k. Against nearly 188 million shares outstanding, the sale equals ~0.005 %, posing no material dilution or governance concern. Absence of recent sales and certification of no undisclosed negative information reduce red-flag risk. Overall, this is a standard liquidity move with minimal market impact.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	600000.00	187826153	06/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/25/2025	Stock Option Exercise	ISSUER			10000	06/25/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Doximity (DOCS) shares are being sold under this Form 144 filing?

10,000 common shares are slated for sale.

What is the aggregate market value of the DOCS shares to be sold?

The filing lists an aggregate value of $600,000.

When is the approximate sale date for these DOCS shares?

The sale is expected on or after 06/25/2025.

What percentage of Doximity’s outstanding shares does this sale represent?

Roughly 0.005 % of the 187,826,153 shares outstanding.

Which broker is handling the DOCS share sale?

The broker of record is Morgan Stanley Smith Barney LLC.